Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Interest heats up in gastrointestinal space

Article Abstract:

Many drug development firms in 2006 are placing bets that irritable bowel syndrome (IBS), a widely prevalent yet poorly understood condition, would become a large, multibillion-dollar revenue opportunity. On a more limited scale, developers of anti-inflammatory biologics are hoping to emulate and extend the initial success of Centorcor's Remicade (infiximab) in treating inflammatory bowel disease (IBD), particularly Crohn disease.

Author: Sheridan, Cormac
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
United States, Forecasts, trends, outlooks, Antiinflammatory Drugs, Forecasts and trends, Drug therapy, Market trend/market analysis, Anti-inflammatory drugs, Anti-inflammatory agents, Irritable bowel syndrome

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


EU to review rare disease drugs market exclusivity

Article Abstract:

Biotech companies that base their business strategy on orphan drug development report for orphan drug pricing are bracing the European Commission (EC). A study is being reviewed on the first eleven orphaned drugs allowed in the European Union.

Author: Sheridan, Cormac
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
United Kingdom, European Union, Powers and duties, Orphan drugs

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Positive clinical data in Parkinson's and ischemia buoy gene therapy

Article Abstract:

Introgen Therapeutics has developed Gene therapies based on the positive clinical data in Parkinson's and ischemia.

Author: Sheridan, Cormac
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Science & research, Anti-Parkinsons Preparations, Care and treatment, Research, Genetic aspects, Parkinson's disease, Parkinson disease, Ischemia, Introgen Therapeutics Inc., Antiparkinsonian agents, Antiparkinson agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Product development, Biotechnology industry, Biotechnology industries
Similar abstracts:
  • Abstracts: Patient safety during medication administration: The influence of organizational and individual variables on unsafe work practices and medication errors
  • Abstracts: Error recovery in a hospital pharmacy. Error detection: A study in anaesthesia. Patient safety in outpatient surgery: The viewpoint of the healthcare providers
  • Abstracts: A suite of objective biomechanical measurement tools for personal load carriage system assessment. Initial force and postural adaptations when pushing and pulling on floor surfaces with good and reduced resistance to slipping
  • Abstracts: The effect of keyboard keyswitch make force on applied force and finger flexor muscle activity. An evaluation of the ergonomics of three computer keyboards
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.